1Doong SL,Tsai CH,Schinazi RF,et al.Inhibition of the replication of hepatitis B virus in vitro by 2^',3^'-dideoxy-3^'-thiacytidine and related analogues.Proc Natl Acad Sci USA,1991,88:8495～8499.
2Tyrrel DLJ,Fischer K,Sayani K et al.Treatment of chimpanzees and ducks with lanmivudine 2^’-3^’-dideoxy-3^’-thiacytidine results in a repid suppression of hepadnaviral DNA in sera.Clin invest Med,1993,16(suppl):77.
3Lai CL,Ching CK,Tung AKM,et al.Lamivudine is effective in suppressing hepatitis B virus DNA in chinese hepatitis B surface antigen carries:a placebo—controlled trial.Hepatology,1 997,25(1):241～244.
4Severini A,Liu XY,Wilson JS,et al.Meshanism of inhibition of duck hepatitis B virus polymerase by(1)-β-2^'-3^’-dideoxy-^3’-thicytdine.Antimicrobial Agents and Chemothery,1995,39:1430～1435.
2Lai CL, Ching CK, Tung AKM, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface e antigen carries : a placebo-controlled trial. Hepatology, 1997, 25:241-244.
3Jung S, Suh D J, Park HJ, et al, Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea. Taehan Kan Hakhoe Chi, 2002,8:418-427.
4Ma H, You H, Yin S. Clinical efficacy of lamivudine in the treatment of chronic hepatitis B. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 2001,15: 147-149.
5van Nunen AB, Hansen BE, Suh D J, et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase. Gut, 2003,52:420-424.
6Jang MK, Chung YH, Choi MH, et al, Combination of alphainterferon with lamivudine reduces viral breakthrough during long-term therapy. J Gastroenterol Hepatol, 2004,19:1363-1368.
7Santantonio T, Mazzola M, Lacovazzi T, et al. Long-term follow-up of patients with anti-Hbe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. J Hepatol,2000,32:300-306.
